News

Stocktwits on MSN5h
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Kennedy ends federal mRNA vaccine projects over experts' objections
RNA technology is credited with ending the COVID-19 pandemic But Department Secretary Robert F. Kennedy, Jr. says it's ...
+27 relevant news
Moderna: RSV Upside Slim, Cash Burn Heavy
Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...
Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
USA Today4y
COVID vaccine from Moderna, Pfizer, AstraZeneca: What's the difference
Moderna, a Cambridge, Massachusetts-based biotechnology company, released data early Monday on its candidate vaccine, mRNA-1273, which was developed in collaboration with the U.S. government.
Moderna Logs Sales Beat Despite Declining Vaccine Demand
Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening ...
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped ...